Theravance (THRX +4.8%) draws some notice from investors after Sanford Bernstein initiates...
Theravance (THRX +4.8%) draws some notice from investors after Sanford Bernstein initiates coverage with an Outperform rating on shares. According to a SEC filing, the biopharmaceutical company also saw some insider buying recently.
From other sites
at CNBC.com (Jun 11, 2014)
at CNBC.com (Dec 6, 2013)
at CNBC.com (Sep 10, 2013)
at CNBC.com (Jun 24, 2013)
at CNBC.com (Apr 15, 2013)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs